Genetics

FORMULATRIX® Digital PCR Technology to Be Acquired by QIAGEN

FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. for up to $260 million ($125 million upfront payment and $135 million of milestones). QIAGEN has announced plans for a global launch…

Diagnomics Partners With Translational Software to Launch Pharmacogenetic Testing Services in the United States

Diagnomics Inc., a San Diego-based genomics solution provider, has extended its product portfolio to include pharmacogenetic (PGx) reporting through a strategic partnership with Translational Software Inc. (TSI). Diagnomics is one of the first companies to offer clinically validated PGx solutions on Illumina’s Global…

New Research Reveals Genetic Engineering Strategies  for Elevating Human Consciousness

New Research Reveals Genetic Engineering Strategies for Elevating Human Consciousness

Researchers at Future Life Institute in Florida have uncovered compelling evidence that sustainable expanded states of awareness can be achieved through genetic engineering. New research has revealed vast reserves of human cognitive potential buried beneath layers of unconscious memories and…

Personalized Lifestyle Medicine Conference Brings Healthcare Professionals to Seattle in October

Personalized Lifestyle Medicine Conference Brings Healthcare Professionals to Seattle in October

The Personalized Lifestyle Medicine Institute (PLMI) will host the Fifth Annual Thought Leaders Consortium this month. This program has attracted international attention and is now sold out. Several hundred health care professionals, research scientists, business leaders, and tech innovators will…

Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific

Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening and High-Risk Cancer Exome Sequencing Tests in Asian Pacific

Baylor Genetics announces a partnership with Hong Kong-based Rainbow Genomics to provide clinical whole exome sequencing tests to patients in Hong Kong, Japan, Singapore and other Asian countries. Product offering includes adult exome screening, high-risk cancer and wellness cancer tests.…

LGS Foundation Announces New Partnership With CURE's Epilepsy Genetics Initiative (EGI) Program

​Today, the LGS Foundation announced a new partnership with the Epilepsy Genetics Initiative (EGI), a signature program of Citizens United for Research in Epilepsy (CURE). The partnership has been designed as a pilot program between the organizations to help more…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login